Search results for "ebola"
Article
Biopharma Manufacturers Respond to Ebola Crisis
8-9
The development of new treatments to combat the lethal Ebola virus has been slow, stymied by difficulties in testing compounds for deadly diseases and the reluctance of both public and private …
Article
Lessons Learned Accelerate Vaccine Development
The successes achieved by leading manufacturers in response to the Ebola outbreak in 2014 suggest that actions can be taken to speed up vaccine development.
Early bioprocessing challenges
The …
Article
Vaccine Development and Production Challenges Manufacturers
Researchers are advancing new vaccines for Ebola and other devastating diseases, while manufacturers work with FDA to bring to market new products to combat dangerous infections and strategies to impr…
Article
Modern Manufacturing Key to More Effective Vaccines
Even though increasingly effective vaccines are eliminating diseases such as polio and diphtheria and helped stem the Ebola outbreak three years ago, promising candidates often fail. Sanofi recently h…
Article
Vaccine Development Faces Urgency and Challenges
By Jill Wechsler
The Ebola outbreak in 2015 and the current stampede to develop a new vaccine to combat the Zika virus illustrate the increasingly important role of vaccines in advancing public he…
Article
Genetic Vaccine Platforms Demonstrate Their Potential
…Pfizer-BioNTech and Moderna for COVID-19 in late 2020 and approval for the viral-vector vaccine for Ebola from Janssen (Ad26.ZEBOV) followed by a second dose of MVA-BN-Filo from Bavarian Nordic, also…
Article
Modeling the Degradation of mAb Therapeutics
…e to their ability to treat a wide range of lethal and life-threatening diseases, including cancer, Ebola (1, 2), multiple sclerosis, rheumatoid arthritis, psoriasis, and asthma. FDA has approved a n…
Article
Modular Manufacturing Platforms for Biologics
Caliber has received inquiries from government officials about whether it could help manufacture ZMapp, a treatment to fight the Ebola virus. Caliber uses G-CON’s pods for its entire downstream proces…